Table 5.
Antimicrobial susceptibility of Gram-negative bacteria from DNF patients (%)
| Antibiotics | Pseudomonas aeruginosa (n = 5) | Klebsiella pneumoniae (n = 5) | Proteus mirabilis (n = 5) | Morganella morganii(n = 4) | Escherichia coli (n = 3) | Proteus penneri (n = 3) | Enterobacter cloacae (n = 2) | Acinetobacter baumannii (n = 2) | Raoultella ornithinol-ytica (n = 2) | Klebsiella oxytoca (n = 2) |
|---|---|---|---|---|---|---|---|---|---|---|
| Ampicillin | 0.0% | 0.0% | 40.0% | 0.0% | 33.3% | – | – | 0.0% | 0.0% | 0.0% |
| Ampicillin/Sulbactam | 0.0% | 50.0% | 50.0% | 0.0% | 33.3% | 33.3% | 0.0% | 100.0% | 0.0% | 100.0% |
| Piperacillin/Tazobactam | 100.0% | 80.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Piperacillin | 100.0% | – | 100.0% | – | – | – | – | 50.0% | – | – |
| Gentamicin | 100.0% | 75.0% | 25.0% | 66.7% | 66.7% | 66.7% | 100.0% | 100.0% | 100.0% | 100.0% |
| Amikacin | 100.0% | 100.0% | 100.0% | 75.0% | 66.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Tobramycin | 100.0% | 50.0% | 50.0% | 66.7% | 100.0% | 66.7% | 0.0% | 100.0% | 100.0% | 100.0% |
| Ciprofloxacin | 100.0% | 40.0% | 40.0% | 50.0% | 33.3% | 100.0% | 100.0% | 100.0% | 50.0% | 100.0% |
| Levofloxacin | 100.0% | 80.0% | 80.0% | 75.0% | 33.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cefazolin | 0.0% | 20.0% | 40.0% | 0.0% | 33.3% | 0.0% | – | – | 0.0% | 0.0% |
| Cefuroxime | 0.0% | 100.0% | 66.7% | 0.0% | – | 0.0% | 50.0% | 0.0% | 100.0% | 100.0% |
| Cefuroxime Axetil | 0.0% | 100.0% | 50.0% | 0.0% | – | – | 0.0% | 0.0% | 100.0% | 100.0% |
| Ceftriaxone | 0.0% | 60.0% | 60.0% | 75.0% | 33.3% | 66.7% | 100.0% | 100.0% | 100.0% | 100.0% |
| Ceftazidime | 100.0% | 60.0% | 100.0% | 100.0% | 66.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cefepime | 100.0% | 80.0% | 60.0% | 100.0% | 66.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cefotetan | 0.0% | 100.0% | 100.0% | 100.0% | 66.7% | 100.0% | 0.0% | 0.0% | 100.0% | 100.0% |
| Cefoxitin | – | 100.0% | 66.7% | 66.7% | 66.7% | 100.0% | 0.0% | – | 50.0% | 100.0% |
| Aztreonam | 100.0% | 60.0% | 100.0% | 100.0% | 66.7% | 100.0% | 100.0% | 0.0% | 100.0% | 100.0% |
| Imipenem | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Ertapenem | – | 100.0% | 100.0% | 100.0% | 66.7% | 100.0% | 100.0% | – | 100.0% | 100.0% |
| Meropenem | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Sulfamethoxa-zole | 0.0% | 60.0% | 40.0% | 33.3% | 100.0% | 33.3% | 66.7% | 100.0% | 50.0% | 100.0% |
| Cefoperazone/sulbactam | 100.0% | 75.0% | 100.0% | 100.0% | 66.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Minocycline | 0.0% | 50.0% | 0.0% | 0.0% | 33.3% | – | 50.0% | 100.0% | 100.0% | 100.0% |
| Doxycycline | 0.0% | – | – | – | – | – | – | 100.0% | – | – |
| Tigecycline | 0.0% | 100.0% | 0.0% | 0.0% | 100.0% | 0.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Nitrofurantoin | – | 100.0% | 0.0% | 0.0% | – | 0.0% | – | – | – | – |
| Amoxicillin/clavulanate | – | 0.0% | 0.0% | 0.0% | – | – | 0.0% | 100.0% | 100.0% | |
| Ticacillin/clavulanate | 50.0% | – | – | – | – | – | – | – | – | – |
The antimicrobial agent in the antimicrobial susceptibility testing changes from year to year, so the sensitivity rate is calculated based on the number of bacteria that have actually tested the antimicrobial agent